Position
Squarepoint Ops LLC in Niagen Bioscience, Inc.
Back to the book · All holders of NAGE
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$180.1K$6.36 → $4.41
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 161.2K | $1.02M | — | — | — | 0.0% |
| Q1 2026 | 92.3K | $407.2K | $4.41 | −$180.1K | −$437.6K | 0.0% |